Monoclonal Antibody against TNF: A Non-Antibiotic Strategy for the Treatment of Sepsis
作者： L. D. Saravolatz , R. A. Pokriefka , N. Markowitz
DOI: 10.1007/978-3-642-84904-6_9
关键词:
摘要: The management of sepsis has been a challenging and perplexing field for clinicians, investigators, basic scientists. persistently high mortality over the several decades that antibiotics have available suggests an additional approach can no longer emphasize only antimicrobial supportive therapies.
springer.com
sci-hub.st 参考文章(20)
Dinarello Ca, Revhaug A, Michie Hr, Manogue Kr, Sherman Ml, Wolff Sm, O'Dwyer St, Cerami A, Arthur K, Spriggs Dr, Tumor necrosis factor and endotoxin induce similar metabolic responses in human beings. Surgery. ,vol. 104, pp. 280- 286 ,(1988)
F Bauss, W Dröge, D N Männel, Tumor necrosis factor mediates endotoxic effects in mice. Infection and Immunity. ,vol. 55, pp. 1622- 1625 ,(1987) , 10.1128/IAI.55.7.1622-1625.1987
G Nyberg, N Anagreus, J Leppert, J Övermo, J Asplund, B Åström, R Bergström, S Kullman, J Lessem, New design for clinical trial of antihypertensive drugs applied to pindolol, clopamide, and combinations thereof. The Lancet. ,vol. 319, pp. 355- 358 ,(1982) , 10.1016/S0140-6736(82)91390-3
K. Tracey, B Beutler, S. Lowry, J Merryweather, S Wolpe, I. Milsark, R. Hariri, T. Fahey, A Zentella, J. Albert, al. et, Shock and tissue injury induced by recombinant human cachectin. Science. ,vol. 234, pp. 470- 474 ,(1986) , 10.1126/SCIENCE.3764421
Eric Girardin, Georges E. Grau, Jean-Michel Dayer, Pascale Roux-Lombard, Paul-Henri Lambert, , Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura. The New England Journal of Medicine. ,vol. 319, pp. 397- 400 ,(1988) , 10.1056/NEJM198808183190703
B Beutler, N Krochin, I. Milsark, C Luedke, A Cerami, Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance Science. ,vol. 232, pp. 977- 980 ,(1986) , 10.1126/SCIENCE.3754653
JOOP M. H. DEBETS, RENÉ KAMPMEIJER, MARIELLE P, WIM A. BUURMAN, CEES J. VAN DER LINDEN, Plasma tumor necrosis factor and mortality in critically ill septic patients. Critical Care Medicine. ,vol. 17, pp. 489- 494 ,(1989) , 10.1097/00003246-198906000-00001
B Beutler, I. Milsark, A. Cerami, Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin Science. ,vol. 229, pp. 869- 871 ,(1985) , 10.1126/SCIENCE.3895437
PIERRE DAMAS, AIMÉE REUTER, PHILIPPE GYSEN, JEAN DEMONTY, MAURICE LAMY, PAUL FRANCHIMONT, Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. Critical Care Medicine. ,vol. 17, pp. 975- 978 ,(1989) , 10.1097/00003246-198910000-00001
Y Fong, K J Tracey, L L Moldawer, D G Hesse, K B Manogue, J S Kenney, A T Lee, G C Kuo, A C Allison, S F Lowry, Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia. Journal of Experimental Medicine. ,vol. 170, pp. 1627- 1633 ,(1989) , 10.1084/JEM.170.5.1627